Proto Labs, Inc. — FY 2022 Form 10-K
Reporting period: Fiscal year ended December 31, 2022. This is an annual filing, not a standalone fourth-quarter report; the supplied filing text does not provide separate Q4 results.
Business context
Proto Labs is a digital manufacturer of custom prototypes and on-demand production parts, using injection molding, CNC machining, 3D printing and sheet metal fabrication. Its 2021 Hubs acquisition added a global network of manufacturing partners. In 2022, the company launched an initial integrated CNC offer in Europe and approved closure of its Japan operations.
Financial performance and liquidity
Amounts below are in U.S. dollars; financial statement amounts are in millions unless otherwise noted.
| Metric | FY 2022 | FY 2021 |
|---|---|---|
| Revenue | $488.4 | $488.1 |
| Gross profit / gross margin | $215.5 / 44.1% | $222.7 / 45.6% |
| Operating income (loss) / margin | $(98.0) / (20.1%) | $40.3 / 8.3% |
| Net income (loss) | $(103.5) | $33.4 |
| Diluted EPS | $(3.77) | $1.21 |
| Cash from operating activities | $62.1 | $55.2 |
| Cash and cash equivalents at year-end | $56.6 | $65.9 |
- Revenue was essentially flat year over year (+0.1%). Growth in CNC machining (+12.9%) and 3D printing (+8.6%) was offset by declines in injection molding (-11.3%) and sheet metal (-4.4%).
- Gross margin fell 1.5 percentage points, primarily due to lower injection molding revenue. Wage inflation also contributed to lower gross margin.
- FY 2022 included a $118.0 million goodwill impairment, writing off all Europe goodwill, and $6.9 million in Japan closure costs. These unusual items drove the operating and net losses.
- Capital expenditures were $21.7 million; net cash used in investing activities was $43.1 million. Share repurchases used $29.7 million of cash. Cash declined by $9.4 million during the year.
- Current assets were $186.6 million and current liabilities were $71.6 million. Marketable securities totaled $50.0 million ($23.6 million short-term and $26.4 million long-term).
- The company reported no financing arrangements at year-end. Lease liabilities totaled $21.4 million, including $17.5 million of finance lease liabilities and $3.8 million of operating lease liabilities.
Material changes and management commentary
- Revenue by geography was $387.4 million in the U.S. (+0.8%), $92.8 million in Europe (+2.6%) and $8.2 million in Japan (-37.9%). Foreign-currency movements reduced international revenue by $11.6 million versus 2021, mainly from the weaker British pound and euro.
- The company served 56,333 unique product developers and engineers, up 1.8%; management said average spend per customer declined, partly due to currency movements.
- Europe reported an operating loss of $130.4 million, compared with operating income of $0.7 million in 2021, primarily reflecting the goodwill impairment. U.S. operating income was $93.2 million, down from $98.0 million.
- Management said existing cash, operating cash generation and interest income should cover anticipated requirements for at least 12 months. It expects future growth capital expenditures, excluding certain building and maintenance costs, to be approximately 8%–12% of annual revenue.
- Management’s strategy is to integrate Protolabs and Hubs into a broader platform, expand customer offerings and pursue long-term revenue growth and improved profitability. The filing gives no specific near-term revenue or earnings guidance.
Risks, contingencies and unusual items
- Key risks include intense competition, economic uncertainty and reduced customer product-development activity; execution and integration of Hubs and platform investments; production capacity, quality and turnaround performance; and supply-chain and labor cost pressures.
- Foreign exchange is a material exposure: the company does not hedge currency risk and states that a hypothetical 10% adverse exchange-rate change could materially affect operating results, although it would generally not materially affect financial position.
- Cybersecurity, customer-data privacy, operational interruptions, facility disruption, intellectual-property claims, product liability, and changing regulation are also identified risks.
- The company does not believe pending ordinary-course litigation is reasonably expected to have a material adverse effect. The filing reports no material unresolved SEC staff comments.
- The independent auditor gave unqualified opinions on the financial statements and internal control over financial reporting; management also concluded controls were effective.
Important facts for investors to verify
- Whether core revenue and customer spending stabilize or improve, particularly in injection molding and Europe, after the 2022 flat revenue result.
- Whether the company’s integrated Protolabs–Hubs platform delivers customer growth, retention and operating efficiencies without further margin pressure.
- The assumptions underlying the $118.0 million Europe goodwill impairment and the performance of the remaining U.S. goodwill balance.
- Cash conversion and capital allocation, including planned growth investment, the $82.3 million remaining repurchase authorization, and lease obligations.
- Costs, timing and operational effects of the Japan exit, and the continued effect of foreign exchange and wage inflation.